These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2876441)

  • 1. Effects of neuroleptic drugs on the inhibition of exploratory behaviour induced by a low dose of apomorphine: implications for the identity of dopamine receptors.
    Ståhle L; Ungerstedt U
    Pharmacol Biochem Behav; 1986 Aug; 25(2):473-80. PubMed ID: 2876441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the selectivity and specificity of the antagonism of apomorphine-induced suppression of exploration by sulpiride.
    Ståhle L; Ungerstedt U
    Psychopharmacology (Berl); 1989; 99(1):75-9. PubMed ID: 2528780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
    Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of different dopamine receptors in rat diphasic motility response to apomorphine.
    Vaccheri A; Dall'Olio R; Gandolfi O; Montanaro N
    Psychopharmacology (Berl); 1986; 89(3):265-8. PubMed ID: 2873607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of SCH 23390, a DA1-receptor antagonist, on the behavioural responsiveness to small and large doses of apomorphine in rats.
    Cuomo V; Cagiano R; Colonna M; Renna G; Racagni G
    Neuropharmacology; 1986 Nov; 25(11):1297-300. PubMed ID: 2948132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D-2 antagonists reverse apomorphine-induced decreased water intake in the rat: prediction of antipsychotic drugs with few extrapyramidal side-effects?
    Ljungberg T
    J Neural Transm; 1989; 76(2):79-90. PubMed ID: 2565360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
    Van Ree JM; Elands J; Király I; Wolterink G
    Eur J Pharmacol; 1989 Aug; 166(3):441-52. PubMed ID: 2572429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulpiride blocks postsynaptic dopamine receptors in the nucleus accumbens.
    Morgenstern R; Fink H
    J Neural Transm; 1985; 61(3-4):151-60. PubMed ID: 3989521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SKF 38393 and apomorphine modify locomotion and exploration in rats placed on a holeboard by separate actions at dopamine D-1 and D-2 receptors.
    Fletcher GH; Starr MS
    Eur J Pharmacol; 1985 Nov; 117(3):381-5. PubMed ID: 3878300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disinhibitory effects of buspirone and low doses of sulpiride and haloperidol in two experimental anxiety models in rats: possible role of dopamine.
    Pich EM; Samanin R
    Psychopharmacology (Berl); 1986; 89(1):125-30. PubMed ID: 2874581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the mode of action of six putative dopamine receptor agonists on suppression of exploratory behaviour in rats.
    Ståhle L; Ungerstedt U
    Psychopharmacology (Berl); 1987; 91(2):139-46. PubMed ID: 3675730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Eur J Pharmacol; 1982 Jun; 81(1):1-9. PubMed ID: 6889533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The production of asymmetry and circling behaviour following unilateral, intrastriatal administration of neuroleptic agents: a comparison of abilities to antagonise striatal function.
    Costall B; Kelly ME; Naylor RJ
    Eur J Pharmacol; 1983 Dec; 96(1-2):79-86. PubMed ID: 6141060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different behavioural patterns induced by the dopamine agonist apomorphine analysed by multivariate statistics.
    Ståhle L; Ungerstedt U
    Pharmacol Biochem Behav; 1986 Feb; 24(2):291-8. PubMed ID: 3952117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic autoreceptor blockade and neuroleptic-induced dopamine receptor hypersensitivity.
    Gordon JH; Clopton JK; Curtin JC; Koller WC
    Pharmacol Biochem Behav; 1987 Feb; 26(2):223-8. PubMed ID: 3575347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated treatment with (-)-sulpiride plus a low dose of SCH 23390 displays wider neuroleptic activity without inducing dopaminergic supersensitivity.
    Dall'Olio R; Gandolfi O; Roncada P; Vaccheri A; Montanaro N
    Psychopharmacology (Berl); 1990; 100(4):560-2. PubMed ID: 1969667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioural and biochemical studies with the benzamide sulpiride in rats.
    Herrera-Marschitz M; Ståhle L; Tossman U; Zetterström T; Ungerstedt U
    Acta Psychiatr Scand Suppl; 1984; 311():147-62. PubMed ID: 6583986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dopamine receptor agonists and antagonists at peripheral neuronal and vascular dopamine receptors in the anaesthetised dog.
    Hilditch A; Drew GM
    J Cardiovasc Pharmacol; 1984; 6(3):460-9. PubMed ID: 6202973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventral tegmental area: site through which dopamine D2-receptor agonists evoke behavioural and electrocortical sleep in rats.
    Bagetta G; De Sarro G; Priolo E; Nisticò G
    Br J Pharmacol; 1988 Nov; 95(3):860-6. PubMed ID: 2974741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of single and long-term administration of sulpiride on open-field and stereotyped behavior of rats.
    Frussa-Filho R; Palermo-Neto J
    Braz J Med Biol Res; 1990; 23(5):463-72. PubMed ID: 2095296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.